Skip to content

Brazilian Diabetes Study: a Type 2 Diabetes Prospective Cohort

Brazilian Diabetes Study: a Type 2 Diabetes Prospective Cohort

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04949152
Acronym
BDS
Enrollment
1046
Registered
2021-07-02
Start date
2016-06-01
Completion date
2026-05-31
Last updated
2021-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Diseases, Coronary Artery Disease, Diabete Mellitus

Keywords

diabetes, cardiovascular disease

Brief summary

Ongoing prospective cohort of type 2 diabetes individuals.

Detailed description

The study population included individuals with type 2 diabetes aged between 40 and 70 years old, living in the metropolitan area of Campinas, Brazil. The volunteers were recruited between 2016 and 2020 through radio, newspaper, television and social media advertisements. A total of 1046 participants were enrolled into the study so far. All participants were firstly invited to an interview with the physician-researcher for medical story register and physical examination. Afterwards, all participants were submitted to the following procedures: blood and urine samples collection, dual-energy X-ray absorptiometry, 6 minutes walk test, hand strength test, bone densitometry test, diabetic polyneuropathy evaluation, advanced glycation end-product measurement, electrocardiogram, echocardiogram, carotid doppler ultrasound, flow-mediated dilation, diabetic retinopathy assessment, ambulatory blood pressure monitoring and cardiac computed tomography for calcium scoring. After full examination, patients were contacted every year for 5 years for endpoints registration. The primary endpoint was a composite of all-cause mortality, myocardial infarction, stroke and myocardial revascularization. Secondary endpoints were end-stage kidney disease requiring dialysis and limb amputation. Study data were collected and managed using REDCap electronic data capture tools.

Interventions

None listed

Sponsors

University of Campinas, Brazil
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
40 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosed type 2 diabetes * Age between 40 and 70 years old

Exclusion criteria

* Unconfirmed diagnosis of diabetes * Intellectual disability

Design outcomes

Primary

MeasureTime frameDescription
MACE5 yearsAll cause death, myocardial infarction, stroke, myocardial revascularization

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026